{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"80.8","upperLimit":"100.0","value":"92.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"description":"Overall Survival (OS) is defined as the time from diagnosis to death from any cause, or to the date of last follow-up for survivors. OS was estimated using the method of Kaplan and Meier. 2-year estimates are reported with 95% CI's, as the data are not mature to 72 months.","dispersionType":"95% Confidence Interval","groups":[{"description":"All eligible patients enrolled on the study","id":"OG000","title":"All Eligible Patients (Combination Chemotherapy)"}],"paramType":"NUMBER","populationDescription":"26 patients were enrolled on the protocol, but 1 was deemed ineligible. The ineligible patient was excluded from all analyses.","reportingStatus":"POSTED","timeFrame":"Assessed up to 72 months, reported at 2 years from diagnosis","title":"Overall Survival (OS)","type":"PRIMARY","unitOfMeasure":"percent probability"}